Skip to Main Content

Author Details

Gabi Tarcic
Hadassah Ein-Kerem Medical Center Campus
2004
23
13
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34117033Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal Cancer.Clin Cancer Res2021
33865203Functional measurement of mitogen-activated protein kinase pathway activation predicts responsiveness of RAS-mutant cancers to MEK inhibitors.Eur J Cancer2021
34779417Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.J Clin Invest2021
32144301A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks.Sci Rep2020
32330873gRNA Sequence Heterology Tolerance Catalyzed by CRISPR/Cas in an In Vitro Homology-Directed Repair Reaction.Mol Ther Nucleic Acids2020
30998096CRISPR-Directed Gene Editing Catalyzes Precise Gene Segment Replacement <i>In Vitro</i> Enabling a Novel Method for Multiplex Site-Directed Mutagenesis.CRISPR J2019
31632838Identification of osimertinib-resistant <i>EGFR</i> L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort.Exp Hematol Oncol2019
29464843Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome.Mol Oncol2018
30687813CRISPR-Directed <i>In Vitro</i> Gene Editing of Plasmid DNA Catalyzed by Cpf1 (Cas12a) Nuclease and a Mammalian Cell-Free Extract.CRISPR J2018
29382783SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.Sci Signal2018
29051390Corrigendum: The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression.Genes Dev2017
28286242Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer.J Thorac Oncol2017
27729313Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.Cancer Discov2016
25678558Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.EMBO Mol Med2015
23076209ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype.Cell Adh Migr2013
22198386EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.FASEB J2012
20516477EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors.Sci Signal2010
20811980MAP Kinase activation by receptor tyrosine kinases: in control of cell migration.Methods Mol Biol2010
19836242An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.Curr Biol2009
18832071The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression.Genes Dev2008
17322878A module of negative feedback regulators defines growth factor signaling.Nat Genet2007
17643115A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.Nat Cell Biol2007
15265913MHC class I-independent recognition of NK-activating receptor KIR2DS4.J Immunol2004
  • 1 - 23 of 23

Recommended Authors

Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Victor Olivas
University of California san francisco
Career Start Year 2012
Number of shared co-authors 7
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 1
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 5
Jesse S Boehm
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 2
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 1
Trever G Bivona
University of California san francisco
Career Start Year 2002
Number of shared co-authors 10
Kevin R Brown
College Street, University of Toronto
Career Start Year 2000
Number of shared co-authors 1
Mariano J Alvarez
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 4
Andrea Bertotti
Candiolo Cancer Institute - FPO IRCCS
Career Start Year 2000
Number of shared co-authors 3
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 5
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Michael A White
University of Georgia
Career Start Year 1994
Number of shared co-authors 0
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 0
Livio Trusolino
Candiolo Cancer Institute - FPO IRCCS
Career Start Year 1993
Number of shared co-authors 3
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 3
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 9
Aykut Uren
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 0
Ron Bose
Washington University School of Medicine
Career Start Year 1991
Number of shared co-authors 3
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 7
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 3
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 3
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 3
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 2
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 4
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 2

Collaborators

Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 4
Ido Amit
Weizmann Institute of Science
Co-authored papers 4
Tal Shay
Co-authored papers 3
Zohar Barbash
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Eran Segal
Weizmann Institute of Science
Co-authored papers 2
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Yiling Lu
Co-authored papers 2
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Shelley L Berger
Penn Epigenetics Institute, Perelman School of Medicine
Co-authored papers 2
Itay Tirosh
Weizmann Institute of Medical Sciences
Co-authored papers 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 2
Yan Zeng
College of Life Sciences, Nanjing Agricultural University
Co-authored papers 1
Rebecca Nagy
Guardant Health Inc.
Co-authored papers 1
Arie Admon
Co-authored papers 1
Nathan K VanLandingham
University of California San Francisco
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Jennifer R Grandis
University of California san francisco
Co-authored papers 1
Oscar M Rueda
University of Cambridge
Co-authored papers 1
Julie E Bauman
George Washington University
Co-authored papers 1
Michelle Lee
University of California at San Francisco
Co-authored papers 1
Daniel E Johnson
University of California San Francisco
Co-authored papers 1
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Co-authored papers 1
Ja Young Cho
Nakdonggang National Institute of Biological Resources (NNIBR)
Co-authored papers 1
Hua Li
University of California san francisco
Co-authored papers 1
Mi-Ok Kim
University of California san francisco
Co-authored papers 1
Hayarpi Torosyan
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers 1
Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 1
Paul S Mischel
Stanford University
Co-authored papers 1
Nan Jin
University of California San Francisco
Co-authored papers 1
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Release 1.2